| 1 | 2 | 3 | 4 | ||||
---|---|---|---|---|---|---|---|---|
Included in analysis with time-to-exposure restriction | ||||||||
All | Patient with CDI relevant main diagnosis | Controls | Cases with nosocomial CDI | |||||
Mean/N | SD | Mean/N | SD | Mean/N | SD | Mean/N | SD | |
Number of different main diagnosis groups | 5878 | Â | 336 | Â | 296 | Â | 296 | Â |
Costs (real) | 5154 | 10,895 | 8278 | 15,235.38 | 24,407 | 36,589 | 34,749 | 44,208 |
Reimbursement (real) | 5188 | 10,479 | 8198 | 14,390.32 | 22,641 | 34,479 | 33,515 | 48,453 |
Reimbursement-costs (real) | 33 | 3646 | − 79 | 4858.83 | − 1765 | 10,584.12 | − 1233 | 13,145 |
LOS | 7.6 | 8.86 | 10.7 | 11.53 | 25.7 | 21.05 | 34.7 | 28.1 |
Days in hospital at the time of CDI acquisition | Â | Â | Â | Â | Â | Â | 16.99 | 16.39 |
Age | 57.70 | 18.68 | 62.70 | 16.46 | 61.04 | 16.48 | 63.61 | 15.76 |
CCI | 1.90 | 2.80 | 3.48 | 3.32 | 4.37 | 3.54 | 4.83 | 3.36 |
Died | 2.02% | Â | 5.05% | Â | 7.43% | Â | 11.98% | Â |
Intensive care (h) | 104.8 | 340.8 | 158.5 | 439.5 | 456.8 | 948.1 | 806 | 1352 |
Comorbidities | N/% | Â | N/% | Â | N/% | Â | N/% | Â |
Number of SD (N) | 6.58 | Â | 9.27 | Â | 14.91 | Â | 20.53 | Â |
Renal failure (N.18) | 7.3% | Â | 12.4% | Â | 17% | Â | 19.6% | Â |
Heart failure (I.50) | 2.7% | Â | 4.2% | Â | 6% | Â | 8.2% | Â |
Ischemic heart disease (I.25) | 10.1% | Â | 14.5% | Â | 14% | Â | 17.2% | Â |
Diabetes (E.11) | 10.9% | Â | 15.3% | Â | 15% | Â | 18.5% | Â |
Hypertension (I.10) | 31.7% | Â | 37.2% | Â | 34% | Â | 38.5% | Â |
Atrial fibrillation and flutter (I.48) | 7.8% | Â | 12.6% | Â | 15% | Â | 20.5% | Â |
Anaemia (D.62) | 5.9% | Â | 9.8% | Â | 20% | Â | 27.5% | Â |
COPD (J.44) | 4.1% | Â | 6.5% | Â | 7% | Â | 8.1% | Â |
Cardiac/vascular implants, grafts (Z.95) | 8.7% | Â | 13.4% | Â | 15% | Â | 14.7% | Â |
Cancer (C.) | 7.4% | Â | 10.2% | Â | 12% | Â | 14.3% | Â |
Observations | 204,914 | Â | 51,857 | Â | 1951 | Â | 559 | Â |